Bob Grant | Apr 26, 2009 | 3 min read
As reported cases of swine flu continue to accumulate (as of today, 40 had been linkurl:reported;http://www.cdc.gov/swineflu/index.htm in the US) and mainstream media outlets dust off their foreboding music tracks and positively scary taglines, a biotechnology company in Maryland says that its approach may speed development of a successful vaccine. Influenza A/South Carolina/1918 (H1N1) VLPsImage: Novavax, Inc.Researchers at Novavax have been developing vaccines for the H5N1 strain of avian flu